Significance of surfactant proteins in respiratory distress syndrome in preterm infants
DOI:
https://doi.org/10.15574/SP.2024.139.88Keywords:
newborns, respiratory distress syndrome, pneumonia, immune status, surfactant protein A, preterm infantsAbstract
Respiratory diseases are considered to be widespread pathologies among preterm infants.
The research aim was to determine the level of surfactant protein A (SP-A) in the blood and tracheobronchial lavage of infants with respiratory distress syndrome (RDS) and pneumonia, as well as to study its significance in predicting pathological processes in the lungs.
Materials and methods. The study involved 80 very low birth weight infants with respiratory distress (2a - subgroup RDS, 2b - pneumonia), 42 extremely low birth weight infants (3a - RDS and 3b - pneumonia subgroups), and 20 children without respiratory distress (control group - 1).
Results. The initial examination showed that the level of SP-A in venous blood in the control group was 2.9±2.3 ng/ml, while in the 2b group, it was 21.2 ng/ml, which was 7.1 times higher compared to the control group. In group 2, the difference between 2b (21.2 ng/ml) and 2a (6.01 ng/ml) was determined to be 3.5 times. A direct correlation was observed between the level of SP-A in the blood and the oxygen dependence of patients with RDS (r=0.240, p<0.05). In addition, an increase in the level of the inflammatory marker C-reactive protein (CRP) was observed in these patients over time, and a correlation was found between the level of SP-A in the blood and CRP. When comparing the level of SP-A between deceased and surviving infants, it was found to be that SP-A 2.9 times higher in the blood of deceased patients compared to surviving infants, and conversely, 2.3 times higher in tracheobronchial lavage in surviving infants compared to the deceased patients. Based on the results obtained, the importance of SP-A in the differential diagnosis and prognosis of RDS is emphasized.
The research was carried out in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the Local Ethics Committee of the institution indicated in the work. The informed consent of the children's parents was obtained for conducting the studies.
No conflict of interests was declared by the authors.
References
Borron P, McCormack FX, Elhalwagi BM. (1998). Surfactant protein A inhibits T cell proliferation via its collagen-like tail and a 210-kDa receptor. Am. J. Physiol. Lung Cell Mol. Physiol. 275: 679-686. https://doi.org/10.1152/ajplung.1998.275.4.L679l PMid:9755099
Borron P, McIntosh JC, Korfhagen TR. (2000). Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am. J. Physiol. Lung Cell Mol. Physiol. 278: 840-847. https://doi.org/10.1152/ajplung.2000.278.4.L840; PMid:10749762
Chroneos ZC, Sever-Chroneos Z, Shepherd VL. (2010). Pulmonary surfactant: an immunological perspective. Cell Physiol Biochem. 25: 13-26. https://doi.org/10.1159/000272047; PMid:20054141 PMCid:PMC3025886
Gardai SJ, Xiao YQ, Dickinson M. (2003). By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell. 115: 13-23. https://doi.org/10.1016/S0092-8674(03)00758-X; PMid:14531999
Oberley RE, Snyder JM. (2003). Recombinant human SP-A1 and SP-A2 proteins have different carbohydrate-binding characteristics. Am. J. Physiol. Lung Cell. Mol. Physiol. - 284: 871-881. https://doi.org/10.1152/ajplung.00241.2002; PMid:12505869
Ohuma E, Moller A-B, Bradley E et al. (2023). National, regional, and worldwide estimates of preterm birth in 2020, with trends from 2010: a systematic analysis. Lancet. 402(10409): 1261-1271. https://doi.org/10.1016/S0140-6736(23)00878-4; PMid:37805217
Pastva AM, Wright JR, Williams KL. (2007). Immunomodulatory roles of surfactant proteins A and D: implications in lung disease. Proc. Am. Thorac. Soc. 4: 252-257. https://doi.org/10.1513/pats.200701-018AW; PMid:17607008 PMCid:PMC2647627
Sweet DG, Carnielli VP, Greisen G, Hallman M, Klebermass-Schrehof K, Ozek E et al. (2023). European Consensus Guidelines on the Management of Respiratory Distress Syndrome 2022 Update. 120: 3-23(2). https://doi.org/10.1159/000528914; PMid:36863329 PMCid:PMC10064400
Vieira F, Kung J, Bhatti F. (2017). Structure, genetics and function of the pulmonary associated surfactant proteins A and D: The extra-pulmonary role of these C type lectins. Annals of Anatomy - Anatomischer Anzeiger. 211: 184-201. https://doi.org/10.1016/j.aanat.2017.03.002; PMid:28351530 PMCid:PMC5488808
Zhuravleva LN, Novikova VI. (2019). The Assessment of the Concentration of surfactant protein D in the blood serum and tracheobronchial secretion in respiratory distress syndrome and congenital pneumonia in premature newborns. Vestnik VGMU. 18(6): 43-49. https://doi.org/10.22263/2312-4156.2019.6.43
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Modern pediatrics. Ukraine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “MODERN PEDIATRICS. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
